Lurong Lian

1.1k citations
24 papers · 753 indexed · h-index 17
Topics
Platelet Disorders and Treatments (9 papers)Hemoglobinopathies and Related Disorders (5 papers)Cell Adhesion Molecules Research (5 papers)

In The Last Decade

Lurong Lian

23 papers receiving 744 citations

Peers

Lurong Lian
Comparison fields: 5 of 82
  • Molecular Biology 305
  • Hematology 211
  • Cell Biology 180
  • Physiology 127
  • Oncology 112
Replace Asoka Banno with:
Asoka Banno United States
Tom N. Durrant United Kingdom
A. Oda Japan
Long Cui China
Leisl Packer Australia
Todd M. Quinton United States
Fumi Yanaga Japan
C. Loesberg Netherlands
Joan Papillon Canada
Huzoor Akbar United States
Lurong Lian relative to Asoka Banno United States Asoka Banno's profile →
Citations per field
00.5×1.5×1.8×
Asoka Banno · 1×
Citations per year

Countries citing papers authored by Lurong Lian

Since Specialization
Citations

This map shows the geographic impact of Lurong Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lurong Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lurong Lian more than expected).

Fields of papers citing papers by Lurong Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lurong Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lurong Lian. The network helps show where Lurong Lian may publish in the future.

Co-authorship network of co-authors of Lurong Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Lurong Lian. A scholar is included among the top collaborators of Lurong Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lurong Lian. Lurong Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 25
2 5
3 33
4 26
5
The relative role of PLC and PI3K in platelet activation
4
6 0
7 36
8 28
9 22
10 19
11 28
12 65
13 43
14 52
15 19
16 109
17 49
18 7
19 57
20 9

About Lurong Lian

Lurong Lian is a scholar working on Hematology, Immunology and Allergy and Genetics, having authored 24 papers that have together received 753 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (9 papers), Hemoglobinopathies and Related Disorders (5 papers) and Cell Adhesion Molecules Research (5 papers). The work is most often cited by research in Hematology (211 citations), Immunology and Allergy (88 citations) and Cell Biology (180 citations). Lurong Lian has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Charles S. Abrams, Yanfeng Wang, Toshio Asakura, Dianqing Wu, John Choi, Mortimer Poncz, Edward E. Morrisey, Jeffrey A. Golden, Don Eslin and Joel Bennett. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026